SCHEMBL4022651

SCHEMBL4022651

COc1cc(N(CCF)C(=O)OC(C)(C)C)ccc1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 5/20 0.38
MTNR1B P49286 5/20 0.38
AAK1 Q2M2I8 1/20 0.37
SSTR4 P31391 1/20 0.35
MAPT P10636 1/20 0.35
HDAC1 Q13547 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
MCHR1 Q99705 1/20 0.33
ABCB1 P08183 1/20 0.33
ALDH1A1 P00352 2/20 0.33
RORC P51449 1/20 0.32
RORB Q92753 1/20 0.32
KDM4E B2RXH2 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
F2 P00734 1/20 0.32
GRM4 Q14833 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31342724 0.79 BRD4 (0.43) MTNR1AMTNR1BAAK1MAPTALDH1A1
SCHEMBL4014579 0.79 BRD4 (0.43) MTNR1AMTNR1BAAK1MAPTALDH1A1
SCHEMBL19675253 0.78 AAK1 (0.40) MTNR1AMTNR1BAAK1MAPTALDH1A1
SCHEMBL17920289 0.78 ALDH1A1 (0.36) MAPTMCHR1ALDH1A1KDM4ELMNA
SCHEMBL4016564 0.78 PTPN11 (0.35) MAPTHDAC1HDAC8HDAC6ALDH1A1
SCHEMBL849303 0.76 ALDH1A1 (0.34) MTNR1AMTNR1BAAK1SSTR4HDAC1
SCHEMBL16943188 0.75 SSTR4 (0.39) AAK1SSTR4HDAC1HDAC8HDAC6
SCHEMBL23407763 0.74 NR1I2 (0.36) MAPTKDM4EMAPK1F2
SCHEMBL16943047 0.73 HDAC1 (0.41) AAK1MAPTHDAC1HDAC8HDAC6
SCHEMBL4016562 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7632851-B2 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers NOVARTIS AG (CH) 2009-12-15 US disclosed
EP-1613610-B1 BENZO 1,2,5 OXADIAZOLES AND BENZO 1,2,5 THIADIAZOLES USEFUL AS HISTOPATHOLOGICAL STAINING AGENTS, IMAGING AGENTS AND BIOMARKERS NOVARTIS AG (CH) 2009-07-01 EP disclosed
US-20060093551-A1 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers NOVARTIS AG (CH) 2006-05-04 US disclosed
EP-1613610-A1 BENZO 1,2,5 OXADIAZOLES AND BENZO 1,2,5 THIADIAZOLES USEFUL AS HISTOPATHOLOGICAL STAINING AGENTS, IMAGING AGENTS AND BIOMARKERS Novartis AG (CH) 2006-01-11 EP disclosed
WO-2004087684-A1 BENZO[1,2,5]OXADIAZOLES AND BENZO [1,2,5]THIADIAZOLES USEFUL AS HISTOPATHOLOGICAL STAINING AGENTS, IMAGING AGENTS AND BIOMARKERS NOVARTIS AG (CH) 2004-10-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060093551-A1 Benzo[1,2,5]oxadiazoles and benzol[1,2,5]thiadiazoles useful as histopathological staining agents, imaging agents and biomarkers H1-3, MKI67, H1-5 MTNR1A 2525/4885MTNR1B 2805/4885AAK1 4638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.